Patents Assigned to Helios Shield Ltd.
  • Ultra-violet A (UVA) and ultra-violet C (UVC) system and methods for inactivation, reduction and inhibition of growth of coronavirus
    Patent number: 12458715
    Abstract: A UVA/UVC system for reducing active levels, on a surface, and inhibiting further growth of coronavirus on the surface, wherein the system has no deleterious effects on a human, in particular on a human eye or epidermis and dermis, wherein the system includes: iv) at least one UVA light source; v) at least one UVC light source; and at least one controller connected to each of the at least one UVA light source and the at least one UVC light source, for controlling at least one parameter of each of the UVA light source and UVC light source.
    Type: Grant
    Filed: April 20, 2021
    Date of Patent: November 4, 2025
    Assignee: Helios Shield Ltd.
    Inventor: Andrew Clark Baird Aubert
  • Combination ultra-violet A (UVA) and ultra-violet C (UVC) system for reduction and inhibition of growth of pathogens
    Patent number: 12409245
    Abstract: A UVA/UVC system for reducing levels, on a surface, and inhibiting further growth of at least one pathogen on the surface, wherein the system has no deleterious effects on a human, in particular on a human eye or epidermis and dermis, wherein the system includes: at least one UVA light source; at least one UVC light source; and at least one controller connected to each of the at least one UVA light source and the at least one UVC light source, for controlling at least one parameter of each of the UVA light source and UVC light source.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: September 9, 2025
    Assignee: Helios Shield Ltd.
    Inventor: Andrew Clark Baird Aubert